Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
China flag China · Delayed Price · Currency is CNY
18.46
+1.68 (10.01%)
Jun 20, 2025, 2:45 PM CST

Ningbo Menovo Pharmaceutical Company Description

Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products.

The company’s products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin calcium, atorvastatin calcium, purin bahrain, and other products.

It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous system, gastrointestinal tract, and other therapeutic areas.

Ningbo Menovo Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Ningbo, China.

Ningbo Menovo Pharmaceutical Co., Ltd.
Country China
Founded 2004
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 2,472
CEO Cheng Zhi Yao

Contact Details

Address:
Building1,Ningbo R&D Park
Ningbo, 315048
China
Phone 86 57 4879 16065
Website menovopharm.com

Stock Details

Ticker Symbol 603538
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100002Y25
SIC Code 2834

Key Executives

Name Position
Cheng Zhi Yao GM and Chairman
Gaofeng Ying Director, Chief Financial Officer and Board Secretary
Jian Xu Deputy General Manager